Johns Hopkins researchers have developed a computer simulation that helps predict under which circumstances a new short-course treatment regimen for drug-resistant tuberculosis could substantially ...

Two treatment regimens for a new anti-tuberculosis drug could improve success rates in patient with multidrug resistant (MDR) tuberculosis, at lower costs for patients, researchers say. Results from ...

Tuberculosis (TB) disproportionately affects vulnerable populations including those with limited economic resources, HIV patients, those whose diet is deficient in nutrients and others. Resistant TB ...

Tuberculosis (TB) is the world's biggest infectious disease killer with multidrug-resistant TB (MDR-TB) posing a particular threat to global health. A study shows that resistance to the new MDR-TB ...

Please provide your email address to receive an email when new articles are posted on . Pregnant women treated with regimens including bedaquiline and/or delamanid had positive treatment outcomes.

Copenhagen — At the World Conference on Lung Health this week, Médecins Sans Frontières (MSF) released data from our operational research highlighting that using the World Health Organization (WHO) ...

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

resistance Thimphu patients patients locked contentoutcome," Punakha Rinzin, tuberculosis locked contentpatients Pema patients which locked contentRinzin, Tshechu tuberculosis to locked ...